What are Dual CAR-T cells? Published 2022-10-12 Download video MP4 360p Recommendations 12:26 What is an Allogeneic CAR T Cell? 25:57 All About CARVYKTI 16:43 Engineering Better CAR T Cells: An Interview with CRI STAR Yvonne Chen, PhD 27:02 CAR T at UCLA: Driving the Progress of Engineered Cell Therapy | Sarah Larson, MD | UCLAMDChat 54:01 Aspirin and cancer: the emerging evidence 31:15 Multiple Myeloma in 2023: What Patients & Caregivers Need to Know Now! | The Patient Story 1:00:53 DRIVING ANTI-HIV DUO CAR T CELL THERAPY TO THE CLINIC 05:49 T Cell Development and Maturation - T Cells are COOL! 09:58 CAR-T Cells in Multiple Myeloma 42:13 Health Matters 2022: Using the Immune System to Treat Cancer with Ronald Levy, MD 26:28 All about Abecma (Idecabtagene Vicleucel) 27:19 All about ELREXFIO (elranatamab) 11:18 CAR-T Cells: Engineered Cancer Killers 05:18 CAR T-Cell Therapies | High Impact Topic (HIT) 52:45 CAR T-cell Therapy in Multiple Myeloma 05:09 What do you see as the future of AML treatments? #AML 59:12 CAR T-cell Therapy: The Good, The Bad and The Long-Term 2022 06:43 TIL Cell Therapy in Melanoma 11:22 What is FISH testing? How and why is it done? Similar videos 03:18 Evaluating dual-targeting CD19/22 CAR-T cells in patients with R/R ALL 03:52 Is CAR T-cell therapy being used to treat newly diagnosed multiple myeloma? 01:52 Opportunities and challenges for dual-targeting CAR-T therapy in ALL 55:10 CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine 05:25 She Travels The World In Her 2022 Mercedes Sprinter 4X4 Camper Van 01:16 Dual-targeting CD30/PDL1 CAR-T therapy in Hodgkin lymphoma 00:45 Bispecific CAR T-cell therapy: combining anti-CD19 and CD22 CAR T-cells 04:37 Developing CAR T-cell therapy for HIV 03:03 Using dual-targeting CAR-Ts to overcome CAF-induced CAR-T resistance in multiple myeloma 02:37 Efficacy of bispecific CD19/CD22 CAR T-cells in B-cell malignancies 04:27 CAR T-cell therapy horizon scan 01:55 Developing the next generation of CAR-T cells 27:28 Mesothelin-specific CAR-T Cell Therapy with HLA-gated Safety Mechanism Selectively Kills Tumor Cells 01:27 IL3-zetakine coupled to a CD33 costimulatory receptor as a dual-targeting CAR approach in AML 05:26 DFIR CAR T-cell therapy for clear cell RCC 09:51 Dual CAR-T therapy for HIV- results of phase II study. More results